Report Content
Chapter 1. Methodology & Scope
1.1. Definition and forecast parameters
1.1.1. Definitions
1.1.2. Methodology and forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
Chapter 2. Executive Summary
2.1. India platelet and plasma industry 3600 synopsis, 2013 – 2024
2.1.1. Country trends
2.1.2. Component trends
2.1.3. Distribution channel trends
2.1.4. Application trends
Chapter 3. Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Major factor analysis
3.3.1. Drivers
3.3.1.1. Increasing prevalence of liver diseases in elderly population
3.3.1.2. Rise in the number of blood transfusions
3.3.1.3. Exclusive use of plasma for treatment of rare disease
3.3.2. Industry pitfalls and challenges
3.3.2.1. Stringent regulatory policies
3.3.2.2. Affordability issue due to high costs
3.4. Porter’s analysis
3.5. Competition review, 2017
3.6. PEST analysis
Chapter 4. India Platelet and Plasma Market, By Component
4.1. Key trends in India platelet and plasma market, by component
4.1.1. Market estimates and forecast, by component, 2013-2024 (USD Million)
4.2. Platelets
4.3. Plasma
Chapter 5. India Platelet and Plasma Market, By Application
5.1. Key trends in India platelet and plasma market, by application
5.1.1. Market estimates and forecast, by application, 2013-2024 (USD Million)
5.2. Hemophilia
5.3. Thrombocytopenia
5.4. Perioperative indications
5.5. Platelet function disorders
5.6. Coagulation factor deficiencies
5.7. Thrombotic thrombocytopenia purpura
5.8. Hemorrhage
5.9. Liver disease
Chapter 6. India Platelet and Plasma Market, By Distribution Channel
6.1. Key trends in India platelet and plasma market, by distribution channel
6.1.1. Market estimates and forecast, by distribution channel, 2013 – 2024 (USD Million)
6.2. Hospitals
6.3. Ambulatory Surgical Centers
Chapter 7. Company Profiles
7.1. Exactech Inc.
7.1.1. Business overview
7.1.2. Financial data
7.1.3. Product landscape
7.1.4. Strategic outlook
7.2. Harvest Terumo BCT
7.2.1. Business overview
7.2.2. Financial data
7.2.3. Product landscape
7.2.4. Strategic outlook
7.3. PlasmaGen Biosciences
7.3.1. Business overview
7.3.2. Financial data
7.3.3. Product landscape
7.3.4. Strategic outlook
7.4. Johnson & Johnson (DePuy Synthes)
7.4.1. Business overview
7.4.2. Financial data
7.4.3. Product landscape
7.4.4. Strategic outlook
7.5. Nuo Therapeutics, Inc.
7.5.1. Business overview
7.5.2. Financial data
7.5.3. Product landscape
7.5.4. Strategic outlook
7.6. Regen Lab SA
7.6.1. Business overview
7.6.2. Financial data
7.6.3. Product landscape
7.6.4. Strategic outlook
7.7. Stryker
7.7.1. Business overview
7.7.2. Financial data
7.7.3. Product landscape
7.7.4. Strategic outlook
7.8. Zimmer Biomet Holdings, Inc
7.8.1. Business overview
7.8.2. Financial data
7.8.3. Product landscape
7.8.4. Strategic outlook
7.9. Indian Red Cross Society
7.9.1. Business overview
7.9.2. Financial data
7.9.3. Product landscape
7.9.4. Strategic outlook
Data Tables
TABLE 1. India platelet and plasma industry 3600 synopsis, 2013 – 2024
TABLE 2. Processing charges for blood components issued by NBTC
TABLE 3. India platelet and plasma market size, by component, 2013 – 2024 (USD Million)
TABLE 4. India platelet and plasma market, by application, 2013 - 2024, (USD Million)
TABLE 5. India platelet and plasma market, by distribution channel, 2013 - 2024, (USD Mn)
Charts & Figures
FIG 1. Industry segmentation
FIG 2. India platelet and plasma market, 2013 – 2024 (USD Million)
FIG 3. Value chain analysis
FIG 4. Growth potential analysis, by component
FIG 5. Growth potential analysis, by application
FIG 6. Growth potential analysis, distribution channel
FIG 7. Porter’s analysis
FIG 8. Strategy Dashboard
FIG 9. PESTEL analysis